Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Entity Address, Postal Zip Code Entity Address, Postal Zip Code Weighted-average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract] n/a Area of additional office space leased Area of Real Estate Property Contract liabilities, additions Contract with Customer, Liability, Increase From Cash Receipts Contract with Customer, Liability, Increase From Cash Receipts Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding 2024 Long-Term Debt, Maturity, Year Two Total property and equipment Property, Plant and Equipment, Gross Consulting services expenses (less than) Related Party Transaction, Expenses from Transactions with Related Party Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Additional paid-in capital Additional Paid in Capital Number of amendments License and Option Agreement, Number Of Amendments License and Option Agreement, Number Of Amendments Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Financial Instruments [Domain] Financial Instruments [Domain] Depreciation and amortization Other Depreciation and Amortization Accrued external research and development costs Accrued Research And Development Costs Current Carrying value as of the balance sheet date of research and development costs. Depreciation expense Depreciation Issuance of common stock upon exercise of options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Operating lease, weighted average discount rate, percent Operating Lease, Weighted Average Discount Rate, Percent Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Domestic Tax Authority Domestic Tax Authority [Member] Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Measurement Input Type [Domain] Measurement Input Type [Domain] Potential common shares Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Future Minimum Payments on the Term Loans Schedule of Maturities of Long-Term Debt [Table Text Block] Equity Component [Domain] Equity Component [Domain] Ownership [Axis] Ownership [Axis] Total assets Assets, Fair Value Disclosure Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Leases Lessee, Operating Leases [Text Block] Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Debt amendment fee included in debt discount Payments of Financing Costs Non-cash lease expense Finance Lease, Right-of-Use Asset, Amortization Related Party [Domain] Related Party [Domain] Plan Name [Axis] Plan Name [Axis] Employment Inducement Incentive Award Plan Employment Inducement Incentive Award Plan [Member] Employment Inducement Incentive Award Plan [Member] Fair value Marketable securities: Debt Securities, Available-for-Sale Dividend yield Measurement Input, Expected Dividend Rate [Member] Vesting period Defined Contribution Plan Employers Matching Contribution Vesting Period Period which an employee's right to exercise a plan is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Supplemental cash flow information Supplemental Cash Flow Information [Abstract] Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Plan Name [Domain] Plan Name [Domain] 2022 (remainder) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Term loan facility Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] Lease Arrangement [Axis] Lease Arrangement [Axis] Lease Arrangement [Axis] Outstanding, term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Accrued interest Accrued Interest, Current Accrued Interest, Current Award Type [Axis] Award Type [Axis] Issuance of common stock, license agreement (in shares) Stock Issued During Period, Shares, New Issues under License Agreement Stock Issued During Period, Shares, New Issues under License Agreement Net cash (used in) operating activities Net Cash Provided by (Used in) Operating Activities 65 Grove Street, Watertown,MA 65 Grove Street, Watertown,MA [Member] 65 Grove Street, Watertown,MA [Member] Lease liability Operating Lease, Liability, Current Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule of Available-for-Sale Marketable Securities Debt Securities, Available-for-Sale [Table Text Block] TAS Partners, LLC (affiliate of Timothy A. Springer, Ph.D.) TAS Partners, LLC [Member] TAS Partners, LLC [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Liability Class [Axis] Liability Class [Axis] Schedule of Cash and Cash Equivalents [Table] Schedule of Cash and Cash Equivalents [Table] Total liabilities Liabilities Operating lease, weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Geographical [Axis] Geographical [Axis] Issuance of common stock and common warrants Stock Issued During Period, Value, New Issues Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Marketable securities Debt Securities, Available-for-Sale, Current Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Weighted-average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Increase in restricted cash Line of Credit Facility, Increase (Decrease), Net Assets: Assets, Fair Value Disclosure [Abstract] Unvested at beginning of period (in dollars per share) Unvested at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Debt Debt Disclosure [Text Block] Operating expenses: Cost of Revenue [Abstract] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Entity Shell Company Entity Shell Company Aggregate amount of upfront and milestone-based payments Aggregate Amount Of Upfront And Milestone Based Payments Paid Aggregate Amount Of Upfront And Milestone Based Payments Paid 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Loan payable Loans Payable, Current Laboratory equipment Laboratory Equipment [Member] Represents information pertaining to laboratory equipment. Aggregate amount for future payments upon achievement of clinical and regulatory approval milestones for products containing ImmTOR platform Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform Series B Preferred Stock Purchase Agreement Series B Preferred Stock Purchase Agreement [Member] Series B Preferred Stock Purchase Agreement Financial Instrument [Axis] Financial Instrument [Axis] 2025 Long-Term Debt, Maturity, Year Three Affiliated Entity Affiliated Entity [Member] Other comprehensive income (loss): Other Comprehensive Income (Loss), Tax [Abstract] Schedule of Changes in Contract Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Document Period End Date Document Period End Date Equity securities, stock purchase agreement, par value per share (in dollars per share) Equity Securities, Stock Purchase Agreement, Par Value Per Share Equity Securities, Stock Purchase Agreement, Par Value Per Share Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Total assets Assets Debt Disclosure [Abstract] Debt Disclosure [Abstract] Net income (loss) per share: Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accrued expenses Accrued expenses Accrued Liabilities, Current Underwriting Agreement Underwriting Agreement [Member] Underwriting Agreement Less: Current portion of loan payable Long-Term Debt, Current Maturities Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Number of obligations Revenue, Number Of Performance Obligations Revenue, Number Of Performance Obligations Payroll and employee related expenses Employee-related Liabilities, Current Variable lease cost Variable Lease, Cost Contract assets, current Contract with Customer, Asset, before Allowance for Credit Loss, Current Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Net Income (Loss) Per Share Earnings Per Share [Text Block] Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Schedule of Weighted Average Assumptions Used Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Number of claims settled Loss Contingency, Claims Settled, Number Award Type [Domain] Award Type [Domain] Class of warrant or right, number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Weighted average period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition MIT Exclusive Patent License Agreement With Massachusetts Institute Of Technology [Member] Represents information pertaining to Exclusive patent license agreement with Massachusetts Institute of Technology. " Proceeds from issuance of common stock under Employee Stock Purchase Plan Proceeds from Stock Plans Issuance of vested restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Gross Computer equipment and software Computer Equipment [Member] Payment made for investments Payments to Acquire Other Investments Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Entity Registrant Name Entity Registrant Name Issuance of common stock and common warrants (in shares) Stock Issued During Period, Shares, New Issues Subsequent Events Subsequent Events [Text Block] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Non-employee consultants Non Employee Stock Option [Member] An arrangement whereby a non-employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Entity Address, City or Town Entity Address, City or Town Defined Contribution Plan Retirement Benefits [Text Block] Leases [Abstract] Leases [Abstract] Expected life (in years) Measurement Input, Expected Term [Member] Period after first commercial sale when the Company is eligible to receive royalties Eligible Period To Receive Royalties Eligible Period To Receive Royalties Estimated forfeitures rate Share-based Compensation Arrangement By Share-based Payment Award Forfeitures Rate Represents the percentage of forfeitures rate of the stock options based on the historical trends. ESPP Employee Stock Purchase Plan2016 [Member] Represent information pertaining to the 2016 Employee Stock Purchase Plan. Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Trading Symbol Trading Symbol Entity File Number Entity File Number 2016 Plan Stock Incentive Plan2016 [Member] Represents the information pertaining to the 2016 stock incentive plan, which provides for the granting of stock based awards to employees, directors, and consultants under terms and provisions established by the board of directors. Deferred revenue Long-term contract liability Contract with Customer, Liability, Noncurrent Research and development Research and Development Expense Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Equity offering costs in accrued liabilities Equity Offering Costs In Accrued Liabilities Equity Offering Costs In Accrued Liabilities Restricted cash and cash equivalents Restricted Cash and Cash Equivalents Grants in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Vested, term Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Money market funds (included in cash equivalents) Cash and Cash Equivalents, Fair Value Disclosure Contract liabilities: Change In Contract With Customer, Liability [Roll Forward] Change In Contract With Customer, Liability [Roll Forward] Ginkgo Agreement Ginkgo Agreement [Member] Ginkgo Agreement Accounts payable Increase (Decrease) in Accounts Payable Fair value as of December 31, 2021 Fair value as of September 30, 2022 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Subsequent Events [Abstract] Subsequent Events [Abstract] Marketable Securities and Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Investment income Investment Income, Net Income Taxes Income Tax Disclosure [Text Block] Credit Facility [Domain] Credit Facility [Domain] Exercise price (in dollars per share) Exercise price, beginning balance (in dollars per share) Exercise price, ending balance (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Basic (in dollars per share) Earnings Per Share, Basic 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Schedule of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders’ equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Forfeited in period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Ownership [Domain] Ownership [Domain] Entity Interactive Data Current Entity Interactive Data Current Sale of stock, number of shares issued in transaction (in shares) Stock issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Schedule Of Changes In The Warrant Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Money market funds (included in cash equivalents) Money Market Funds [Member] Accumulated deficit Retained Earnings [Member] Unrecognized compensation expense related to unvested employee stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Total lease cost Lease, Cost Common stock Common Stock [Member] Schedule of Lease, Cost Lease, Cost [Table Text Block] Number of shares authorized for grants (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Statement [Table] Statement [Table] Vested in period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Document Quarterly Report Document Quarterly Report Letter of credit Letter of Credit [Member] Furniture and fixtures Furniture and Fixtures [Member] Current assets: Assets, Current [Abstract] Lease liability Operating Lease, Liability, Noncurrent Research and development credits Deferred Tax Assets, Tax Credit Carryforwards, Research Vested Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Intrinsic Value Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Intrinsic Value Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Employer contribution made, net Defined Contribution Plan, Cost Leasehold improvements Leasehold Improvements [Member] Weighted-average fair value of common stock (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Fair Value Weighed-average fair value relating to the share-based payment award. Accumulated deficit Retained Earnings (Accumulated Deficit) Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current U.S. government agency securities and treasuries US Treasury and Government [Member] Equity Components [Axis] Equity Components [Axis] Deferred revenue, additions Contract with Customer, Liability, Deferred Revenue, Increase From Cash Receipts Contract with Customer, Liability, Deferred Revenue, Increase From Cash Receipts Recurring Fair Value, Recurring [Member] Milestone receivable for certain dystrophies License And Option Agreement, Milestone Receivable For Certain Dystrophies License And Option Agreement, Milestone Receivable For Certain Dystrophies Related-party Transactions Related Party Transactions Disclosure [Text Block] Contractual payments defined in the Exclusive Patent License agreement License And Option Agreement, Contractual Payments Made License And Option Agreement, Contractual Payments Made Document Fiscal Year Focus Document Fiscal Year Focus Takeda Agreement Takeda Agreement [Member] Takeda Agreement Statement [Line Items] Statement [Line Items] Warrants and rights outstanding, term Warrants and Rights Outstanding, Term Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Unvested at beginning of period (in shares) Unvested at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Redemption premium Redemption Premium Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Schedule of Operating Lease, Lease Income Operating Lease, Lease Income [Table Text Block] Unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Right-of-use asset, net Operating Lease, Right-of-Use Asset Accumulated other comprehensive loss AOCI Attributable to Parent [Member] Weighted average exercise price Class Of Warrant Or Right, Exercise Price Of Warrants Or Rights [Roll Forward] Class Of Warrant Or Right, Exercise Price Of Warrants Or Rights Vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Document Transition Report Document Transition Report Local Phone Number Local Phone Number Extension term License And Option Agreement, Extension Term License And Option Agreement, Extension Term Equity securities, stock purchase agreement, purchase price per share (in dollars per share) Equity Securities, Stock Purchase Agreement, Purchase Price Per Share Equity Securities, Stock Purchase Agreement, Purchase Price Per Share Schedule of Options Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Operating income (loss) Operating Income (Loss) Federal operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Domestic Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] 2019 Warrants 2019 Warrants [Member] 2019 Warrants Investments Equity securities without readily determinable fair value, amount Equity Securities without Readily Determinable Fair Value, Amount Prepaid expenses, deposits and other assets Increase (Decrease) in Prepaid Expense and Other Assets Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Total liabilities Liabilities, Fair Value Disclosure Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income tax (expense) benefit Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] SOBI Purchase Agreement SOBI Purchase Agreement [Member] SOBI Purchase Agreement [Member] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Cost share percentage Collaborative Arrangement, Cost Share Percentage Collaborative Arrangement, Cost Share Percentage 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Additional paid-in capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Net income (loss) per share: Earnings Per Share, Basic [Abstract] Venture debt termination fee Debt Instrument, Termination Fee Debt Instrument, Termination Fee Diluted (in shares) Weighted‑average common shares outstanding—diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Expected term Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement Collaborative Arrangement [Member] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Common stock, $0.0001 par value; 350,000,000 and 200,000,000 shares authorized as of September 30, 2022 and December 31, 2021, respectively; 153,028,822 and 123,622,965 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively Common Stock, Value, Issued Future additional payments, expected License And Option Agreement, Future Additional Payments, Expected License And Option Agreement, Future Additional Payments, Expected Grants in period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Cash, cash equivalents, restricted cash and marketable securities Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Debt Securities, Available-For-Sale Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Debt Securities, Available-For-Sale Issuance of vested restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Schedule of Potential Common Shares Issuable Upon Conversion of Warrants Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Underwriting Agreement - 2022 Warrants Underwriting Agreement - 2022 Warrants [Member] Underwriting Agreement - 2022 Warrants Schedule of Assets Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price Equity securities, stock purchase agreement, shares purchased (in shares) Equity Securities, Stock Purchase Agreement, Shares Purchased Equity Securities, Stock Purchase Agreement, Shares Purchased Short-term lease cost Short-Term Lease, Cost Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Accrued professional and consulting services Accrued Audit Fees, Current Accrued Audit Fees, Current Number of Warrants Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Foreign currency translation adjustment Currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Warrants and rights outstanding, measurement input Warrants and Rights Outstanding, Measurement Input Current liabilities: Liabilities, Current [Abstract] Adjusted net income (loss) Net Income (Loss) Available to Common Stockholders, Basic Proceeds from exercise of stock options Proceeds from Stock Options Exercised Common stock, shares issued (in shares) Common Stock, Shares, Issued Vested and expected to vest, term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Deferred revenue Short-term contract liability Contract with Customer, Liability, Current Purchase of property and equipment not yet paid Capital Expenditures Incurred but Not yet Paid Foreign currency transaction, net Foreign Currency Transaction Gain (Loss), before Tax Warrant liabilities Warrant liabilities Warrants and Rights Outstanding Spark License Agreement License Agreement Terms [Member] Income Statement Location [Domain] Income Statement Location [Domain] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Net cash (used in) investing activities Net Cash Provided by (Used in) Investing Activities Operating lease cost Operating Lease, Cost Face value Debt Instrument, Face Amount Issuance of common stock under Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Total comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Construction in process Construction in Progress [Member] Unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Entity Current Reporting Status Entity Current Reporting Status Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Long-term Debt, Fiscal Year Maturity [Abstract] Long-Term Debt, Fiscal Year Maturity [Abstract] License and option agreement, written day notice period before cancellation License And Option Agreement, Written Day Notice Period Before Cancellation License And Option Agreement, Written Day Notice Period Before Cancellation Development milestone License And Option Agreement, Development Milestone License And Option Agreement, Development Milestone Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. [Member] Sarepta Therapeutics, Inc. [Member] Term of contract Lessee, Operating Lease, Term of Contract Issuance of common stock under Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Counterparty Name [Axis] Counterparty Name [Axis] Schedule of Related Party Transactions Schedule of Related Party Transactions [Table Text Block] Founders Founder [Member] Represents information pertaining to founder member. Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Less: Debt discount Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Number of shares authorized, increase (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease) Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease) Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Deferred revenue, beginning of period Deferred revenue, end of period Contract with Customer, Liability, Deferred Revenue Contract with Customer, Liability, Deferred Revenue Less: Change in fair value of liability warrants Preferred Stock Dividends and Other Adjustments Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Effect of exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Cash paid for amounts included in the measurement of lease liabilities: Operating Lease, Payments Office equipment Office Equipment [Member] Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Outstanding common stock options Share-Based Payment Arrangement, Option [Member] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value [Abstract] n/a Issuance of common stock upon exercise of options Stock Issued During Period, Value, Stock Options Exercised Forfeited in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Total minimum principal payments Long-Term Debt Other income, net Other Nonoperating Income (Expense) Share price (in dollars per share) Sale of Stock, Price Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Total operating expenses Collaboration expense Operating Expenses Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Employees Shares available for future stock incentive awards Employee stock option grants Share-Based Payment Arrangement [Member] Long-term restricted cash Restricted Cash and Cash Equivalents, Noncurrent Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Deferred revenue Increase (Decrease) in Contract with Customer, Liability Total current assets Assets, Current Income taxes payable Taxes Payable, Current Revenue recognized Contract liabilities, deductions Contract with Customer, Liability, Revenue Recognized Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Smaller Reporting Company Entity Small Business Schedule of Stockholders' Equity Note, Warrants or Rights Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Measurement Frequency [Domain] Measurement Frequency [Domain] Equity Stockholders' Equity Note Disclosure [Text Block] Shares of common stock issued to employees under the ESPP (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Valuation technique, option pricing model Valuation Technique, Option Pricing Model [Member] Line of Credit Facility [Table] Line of Credit Facility [Table] Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Operating lease, expense Operating Lease, Base Rent Operating Lease, Base Rent Non-cash interest expense Paid-in-Kind Interest Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Description of the Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net Payables and Accruals [Abstract] Payables and Accruals [Abstract] Debt Instrument [Line Items] Debt Instrument [Line Items] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Class of Stock [Line Items] Class of Stock [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Lease liabilities Operating Lease, Liability Expected volatility Measurement Input, Price Volatility [Member] Amortization of premiums and discounts on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Issuance of common stock, license agreement Stock Issued During Period, Value, New Issues under License Agreement Stock Issued During Period, Value, New Issues under License Agreement Other financing fees Adjustments to Additional Paid in Capital, Other AskBio License AskBio License [Member] AskBio License [Member] Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Milestone receivable License And Option Agreement, Milestone Receivable License And Option Agreement, Milestone Receivable Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Amortized cost Debt Securities, Available-for-Sale, Amortized Cost Weighted average common shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Sale common stock Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Accounts payable Accounts Payable, Current Income Tax Authority [Axis] Income Tax Authority [Axis] Debt discount Debt Instrument, Unamortized Discount Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Canceled (in dollars per share) Warrant, Exercise Price, Canceled Warrant, Exercise Price, Canceled Warrants to purchase common stock Warrant liabilities Exercise of warrants Warrant [Member] Entity Filer Category Entity Filer Category Net proceeds from issuance of common stock- at-the-market offering Shares issued, value Proceeds from Issuance of Common Stock Basic (in shares) Weighted-average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Loss contingency accrual Loss Contingency Accrual Liabilities: Liabilities, Fair Value Disclosure [Abstract] Total stock-based compensation expense Stock-based compensation expense Share-Based Payment Arrangement, Expense Cyrus Biotechnology, Inc. Cyrus Biotechnology, Inc. [Member] Cyrus Biotechnology, Inc. Noncash investing and financing activities Noncash Investing and Financing Items [Abstract] Commitments and contingencies Commitments and Contingencies Lease Arrangement [Domain] Lease Arrangement [Domain] [Domain] for Lease Arrangement [Axis] Security Exchange Name Security Exchange Name Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Issuance of common stock, license agreement in stock-based compensation expense Stock Issued At-The-Market Offering At-The-Market Offering [Member] At-The-Market Offering [Member] Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of September 30, 2022 and December 31, 2021 Preferred Stock, Value, Issued License Agreement For Pompe Disease License Agreement For Pompe Disease [Member] License Agreement For Pompe Disease [Member] Restricted cash Letters of Credit Outstanding, Amount 2020 Term Loans 2020 Term Loans [Member] 2020 Term Loans Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Schedule of Term Loan And Unamortized Debt Discount Balances Schedule of Debt [Table Text Block] General and administrative General and Administrative Expense [Member] Collaboration and license revenue Revenue from Contract with Customer, Excluding Assessed Tax Corporate bonds Corporate Bond Securities [Member] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Income taxes payable Increase (Decrease) in Income Taxes Payable Contract assets, noncurrent Contract with Customer, Asset, before Allowance for Credit Loss, Noncurrent Total (in shares) Common stock authorized and reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Cover [Abstract] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] License and option agreement, payments made relative to calculated premium paid for initial equity investment made under the purchase agreement License And Option Agreement, Calculated Premium Paid For Equity Investment Under Purchase Agreement License And Option Agreement, Calculated Premium Paid For Equity Investment Under Purchase Agreement Level 3 Fair Value, Inputs, Level 3 [Member] Stock Incentive Plans Share-Based Payment Arrangement [Text Block] Schedule of Stock-Based Compensation Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Other assets Other Assets Revenue Arrangements Revenue from Contract with Customer [Text Block] 3SBio License License Agreement With Shenyang Sunshine Pharmaceutical Company Limited [Member] Represents information pertaining to License agreement with Shenyang Sunshine Pharmaceutical co., ltd. Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Total liabilities and stockholders’ equity Liabilities and Equity Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] 2022 Warrants 2022 Warrants [Member] 2022 Warrants Related Party [Axis] Related Party [Axis] Cash maintained in Russian bank accounts Cash Sales milestone payments License And Option Agreement, Sales Milestone Payments That May Be Received License And Option Agreement, Sales Milestone Payments That May Be Received Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Issuances Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Level 2 Fair Value, Inputs, Level 2 [Member] Net proceeds from issuance of common stock and common warrants Proceeds From Issuance Of Common Stock And Warrants Proceeds From Issuance Of Common Stock And Warrants Current Fiscal Year End Date Current Fiscal Year End Date Option term License And Option Agreement, Option Term License And Option Agreement, Option Term Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Adjusted net income (loss) Net Income (Loss) Available to Common Stockholders, Diluted Diluted (in dollars per share) Earnings Per Share, Diluted Sale of Stock [Domain] Sale of Stock [Domain] Award vesting term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Gain) on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Schedule of Authorized Shares of Common Stock for Future Issuance Schedule of Stock by Class [Table Text Block] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Change in fair value of warrant liabilities Warrant liabilities revaluation Fair Value Adjustment of Warrants Total current liabilities Liabilities, Current Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Russian subsidiary RUSSIAN FEDERATION Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Non-current liabilities: Other Liabilities, Noncurrent [Abstract] Schedule of Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Contract assets Contract with Customer, Asset, before Allowance for Credit Loss Income Tax Authority [Domain] Income Tax Authority [Domain] Deferred revenue related to agreement Contract liabilities, beginning of period Contract liabilities, end of period Contract with Customer, Liability 2008 Plan, 2016 Plan, and 2018 Inducement Incentive Award Plan 2008 Plan, 2016 Plan, and 2018 Inducement Incentive Award Plan [Member] 2008 Plan, 2016 Plan, and 2018 Inducement Incentive Award Plan Research and development Research And Development [Member] Represents the information pertaining to research and development expenses included in the income statement. Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Interest expense Interest Expense Credit Facility [Axis] Credit Facility [Axis] Unrealized (losses) on marketable securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Accrued patent fees Accrued Patent Fees Current Carrying value as of the balance sheet date of patent fees. Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Unrealized (losses) on marketable securities Marketable Securities, Unrealized Gain (Loss) Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Equity [Abstract] Equity [Abstract] Vested in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Unvested restricted stock units Restricted Stock Units, Unvested [Member] Restricted Stock Units, Unvested Entity Tax Identification Number Entity Tax Identification Number Exercises Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Exercises In Period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Exercises In Period Issuances (in shares) Stock Issued During Period Shares Warrants Issued Stock Issued During Period Shares Warrants Issued Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Thereafter Lessee, Operating Lease, Liability, To Be Paid, After Year Four Lessee, Operating Lease, Liability, To Be Paid, After Year Four Issuance of common stock through at-the-market offering, net (in shares) Stock Issued During Period, Shares, Other Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Net change in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Exercise of warrants (in shares) Stock Issued During Period Shares Warrants Exercised Number of warrants exercised during the current period. Dilutive effect of employee equity incentive plans and outstanding warrants (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Commercial paper Commercial Paper [Member] Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Payment obligation Collaborative Arrangement, Payment Obligation Collaborative Arrangement, Payment Obligation Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Initial upfront execution fee payment License And Option Agreement, Execution Fee Payment License And Option Agreement, Execution Fee Payment Canceled (in shares) Stock Issued During Period, Shares, Warrants Canceled Stock Issued During Period, Shares, Warrants Canceled Other Other Accrued Liabilities, Current Measurement Input Type [Axis] Measurement Input Type [Axis] City Area Code City Area Code General and administrative General and Administrative Expense Assets Assets [Abstract] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Collaboration and License Agreements Collaboration And License Agreements [Text Block] Collaboration And License Agreements Issuance (in dollars per share) Warrant, Exercise Price, Increase Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Sale of Stock [Axis] Sale of Stock [Axis] Proceeds from maturities of marketable securities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Clinical and commercial milestone payment, expected License And Option Agreement, Clinical And Commercial Milestone Payment, Expected License And Option Agreement, Clinical And Commercial Milestone Payment, Expected 2023 Long-Term Debt, Maturity, Year One Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Upfront cash payment License And Option Agreement, Upfront Cash Payment License And Option Agreement, Upfront Cash Payment Weighted average grant date fair value of stock options (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Issuance of common stock through at-the-market offering, net Stock Issued During Period, Value, Other Initial up-front cash payment License And Option Agreement, Initial Up-Front Cash Payment License And Option Agreement, Initial Up-Front Cash Payment Revenue recognized from performance obligations related to prior periods as a result of the change in transaction price Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price Class of warrant or right, outstanding, beginning balance (in shares) Class of warrant or right, outstanding, ending balance (in shares) Class of Warrant or Right, Outstanding Loan payable, net of current portion Loans Payable, Noncurrent Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Schedule of Computation of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Milestone payment License And Option Agreement, Milestone Payments License And Option Agreement, Milestone Payments Deferred revenue, deductions Contract with Customer, Liability, Deferred Revenue, Revenue Recognized Contract with Customer, Liability, Deferred Revenue, Revenue Recognized